Home

Pharmarise Holdings

image

Contents

1. M amp A Pharmarise Holdings Corporation Company Information Session 2 S Re PE MO 2 CE 9 ly a Pharmarise Holdings Corporation Company Information Session 2 Pharmarise 4 HOLDINGS 2
2. Pharmarise Holdings Corporation Company Information Session Pharmarise HOLDINGS z Pharmarise Holdings Corporation Q Company
3. Pharmarise Holdings Corporation Company Information Session sz gt Y gt Pharmarise LN 2 HOLDINGs
4. 3 100 5 3 100 100 100
5. 2013 5 1 5 100 2014 5 2 5 000 mk mp 2013 5 5 2 5 JR 7 9 JR 516 95 Pharmarise 4 HOLDINGS Pharmarise Holdings Corporation Company Information Session ie Z Pharmarise murs 201 2 1 0 31 NO Ce 2014 201 5 2016 5 5 5
6. 2013 5 IL P40 9200 2010 5 800 200 Pharmarise Holdings Corporation Company Information Session lt harmarise km A amp u 2 78868 a i 6 691 338 Pharmarise Holdings Corporation Company Information Session EE armarise SS gt HOLDINGS EN 102 357x OE 154
7. Strengths HB 1 1 2 2 3 4 Re Weaknesses 5 1 O Opportunities ae ea 2 O 2 3 AR 3 Threats Pharmarise Holdings Corporation gt Company Information Session NN Ph lt Forpmes la Pharmarise Holdings Corporation Company Information Session
8. 100 100 100 PTEE lt 100 Phemwe HoMings Comoration Pharmarise ooaeWe a 21 3 SE 206 ent 815 2009 9 5 N5 PS 2009 9 RR 2010 1
9. 5 0 3 7 685 958 Pharmarise Holdings Corporation 2 Company Information Session 1 Ph 2014 5 2 HOLDINGS 12 900 0 6 160 3 643 M amp A 4 2 530 53 4 408 2 ER 399 305 2013 5 2014 5 1 228 A16 5 1 640 33 5 3 7 4 4 958 39 7 700 26 9 Pharmarise Holdings Corporation 2 9 Company Information Session oi4es 1 M amp A 22 6 34 4 2013 5 1
10. 6 Permede Pharmarise Holdings Corporation 5 Company Information Session Pharmarise HOLDINGS Pharmari G013 sa 2 Phamarise M amp A 1 1 2012 5 2013 5 29 607 33357 1657 1470 1 228
11. 2011 9 2012 10 2013 4 2012 11 a 34 0 4 010 3 42 1 201 1 6 Pharmarise Holdings Corporation 68 Company Information Session 9 10 die a 6 2 12 3 2 ee 12 2 i 5 5 5 5 5 5 5 5 5 13 2 10 Pharmarise HOLDINGS armarise ed
12. 2014 5 1 Pharmarise Holdings Corporation Company Information Session Pharmarise 4 HOLDINGS 3 Pharmarise HOLDINGS 50 000 5 000 400 40 000 370 4 000 333 30 000 _236 3 000 20 000 2 000 10 000 1 000 0 Pharmarise Holdings Corporation 3 Company Information Session Pharmarise HOLDINGS Pharmarise Y HOLDINGS se ee ee ee eeeeoeeeee eee eeeee leeoeeeeee 2014 5 1 14 15 ol oe 09 10 GODPCOCO VCO YY 2006 2007 2008 2009 2010 2011 2012 2013 2014 5 5 5 5 5 5 5 5 5 2013 12 1 100 Pharmarise Holdings Corporation 3 Company Information Sess
13. Pharmarise Holdings Corporation 3 Company Information Session gt 800 700 600 500 400 300 200 100 0 Pharmarise HOLDINGS NN NN NN 2014 5 Pharmarise Holdings Corporation Company Information Session J amp A gt nr 4 EK Mer ON rz Pharmarise HOLDINGS SS as
14. ea TEL 03 3362 7130 FAX 03 3362 7190 6 E MAIL ir pharmarise cO jD http www pharmarise com
15. Information Session M amp A mi mn 10 16 3 5 Pharmarise Holdings Corporation Company Information Session 22 Pharmarise HOLDINGS Eg 7iiE 1 HAZ7 ae Nk Pharmarise Holdings Corporation Company Information Session Pharmarise HOLDINGS 3 AN Zz Pharmarise SA ON A DNS EE
16. Pharmarise HOLDINGS 2013 10 18 Pharmarise Holdings Company Information Session 1 2796 JASDAQ Pharmarise Holdings 2 3 Pharmarise Company Information Session HOLDINGS CTSNIS 02 Pharmarise HOLDINGS ee 2013 5 31 2013 8 Pharmarise HOLDINGS Pharmarise Holdings Corporation 213 206 42 56 23 53 38 1 Pharmarise Holdings Corporation 3 Company Information Session 3 1 100
17. ion 11 30 1 2013 12 1 1 100 2013 12 1 1 1 100 3 s We 2ml 3 C Max UPX C 90 1 120 1 Pharmarise Holdings Corporation 3 3 Company Information Session Pharmarise HOLDINGS

Download Pdf Manuals

image

Related Search

Related Contents

43-811型 取扱説明書 保証書付 ガスクリーンヒーティング  Consultez ce catalogue en PDF - Société Royale Forestière de  RAPTOR User Manual 3.0 - Bioinformatics Solutions Inc.  MWPHARM++ USER MANUAL  Gateway LT21 User's Manual  

Copyright © All rights reserved.
Failed to retrieve file